ELENCO VINCITORI “PREMIO PROF. PIERO TRIVELLA”
|
1998 15-17 novembre, Roma |
|
|
Alessandra
Gasbarri |
Differential
expression of CD44V6 isoforms and Galectin-3 in benign and malignant
thyroid lesions. Potential diagnostic implications |
|
Patrizia Pisarra |
Identification
of an alternative transcript encoding a putative soluble form of
tyrosinase-related protein-2 |
|
1999 22-24 novembre, Milano |
|
|
Marina De
Rosa |
Mutations in the PMS2 gene cause autosomal recessive Turcot
Syndrome |
|
Laura
Rosano' |
Endothelin-1
upregulates vascular endothelial growth factor production and stimulates
ovarian tumor cell proliferation and invasion |
|
2000 5-7 ottobre, Torino |
|
|
Davide
Bisacchi |
Human
chorionic β-gonadotropin
has anti-angiogenic properties in vivo |
|
Paola Zancai |
Glucocorticoids
promote the proliferation and antagonize retinoic acid-mediated growth
suppression of ABV-immortalized B lymphocytes |
|
2001 10-13 ottobre, Napoli |
|
|
Chiara
Colombo |
Characterization
of the TRP-2-INT2 antigen, a cytoplasmic novel protein specifically
expressed by transformed but not normal cells of the melanocytic lineage |
|
Roberta Vene' |
Green
tea polyphenol effects on angiogenic tumour growth |
|
2002 27-30 ottobre, Genova |
|
|
Raffaella
Dell'Eva |
Il-12
gene transfer an approach to uveal melanoma therapy |
|
Luca Roz |
Analysis
of the apoptotic pathway induced by the fhit protein in the lung cancer
cell line H460 |
|
2003 9-12 novembre, Bergamo |
|
|
Francesca
Andriani |
Microarray
analysis of the gene expression profile induced by the FHIT protein |
|
Davide Melisi |
Zoledronic
acid (Zometa) in combination with a COX-2 inhibitor and gefitinib ('Iressa')
cooperatively inhibits growth and angiogenic factor expression in breast
and prostate carcinoma cells |
|
2004 24-27 ottobre, Pisa |
|
|
Alessandra
Aloisi |
P73
mediates the apoptotic activity of a nuclear BCR-ABL tyrosine kinase |
|
Sabrina Cattaruzza |
Role
of NG2 proteoglycan in the convergent integrin-independent and FGF
signalling events in soft tissue sarcoma cells |
|
2005 2-5 ottobre, Padova – Abano Terme |
|
|
Katiuscia
Bonezzi |
Induction
of tubulin acetilation by IDN 5390: a possible mechanism of its
antimotility activity |
|
Luisa
Novellino |
Protein-tyrosine
phosphatase receptor K (PTPRK) counteracts melanoma |
2006 1-4 ottobre, Bari |
|
Stefania
Berton |
Role of P27kip1 in v-SRC dependent transformation |
Carmen
Ghilardi |
Identification of novel markers of tumor endothelium |
2007 26-29 novembre, Pordenone |
|
Daniela
Trisciuoglio |
The N-terminal BH4 domain of bcl-2 is required for the proangiogenic properties of bcl-2 |
Alessandra Petrucco |
EMILIN plays protective role in multistep skin carcinogenesis |
2008 6-9 ottobre, Napoli |
|
Carmine Carbone |
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor vorinostat |
Federica Maione |
Role of semaphorin 3A in tumor angiogenesis in transgenic mouse models of carcinogenesis |
2009 23-26 novembre, Sesto San Giovanni (Milano) |
|
Teresa Gelardi |
mTOR inhibitor, everolimus, synergizes with a toll-like receptor 9 (TLR9) agonist, IMO, to inhibitor renal cell carcinoma |
Rosaria Cammarota |
Role of tumor microenvironment in colon-rectal disease |
2010 4-7 ottobre, Roma |
|
Involvement of BH4 domain of bcl-2 and MAPK pathway in the regulation of HIF-1α stability in hypoxic melanoma cells. |
|
Elena Ghiso |
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition |